Eric J. Lawitz, MD

San Antonio, Texas 78215

0 studies enrolling now · 2 studies all time

What they study most

Cirrhosis, Hepatic Impairment, Hepatitis, Hepatitis C, Non-alcoholic Steatohepatitis

Studies at this site

• A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function — Completed
• Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C — Completed